Droms Strauss Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
949
+1
+0.1% +$233 0.05% 76
2026
Q1
$232K Sell
948
-276
-23% -$64.3K 0.06% 73
2025
Q4
$253K Buy
+1,224
New +$242K 0.07% 72
2024
Q4
Sell
-1,242
Closed -$201K 72
2024
Q3
$201K Buy
+1,242
New +$198K 0.07% 65
2023
Q1
Sell
-1,158
Closed -$205K 67
2022
Q4
$205K Buy
+1,158
New +$200K 0.09% 61
2022
Q3
Sell
-1,168
Closed -$206K 65
2022
Q2
$206K Buy
1,168
+17
+1% +$3.03K 0.1% 58
2022
Q1
$205K Buy
+1,151
New +$196K 0.1% 43
2021
Q2
Sell
-1,564
Closed -$257K 53
2021
Q1
$257K Buy
1,564
+2
+0.1% +$324 0.13% 41
2020
Q4
$247K Buy
1,562
+133
+9% +$19.6K 0.14% 38
2020
Q3
$214K Sell
1,429
-223
-13% -$33K 0.13% 44
2020
Q2
$233K Sell
1,652
-281
-15% -$41K 0.16% 34
2020
Q1
$254K Buy
1,933
+55
+3% +$7.8K 0.21% 35
2019
Q4
$275K Buy
+1,878
New +$255K 0.2% 38

Other funds holding JNJ

Droms Strauss Advisors's JNJ Position: Q2 2026 in Review

Droms Strauss Advisors increased its Johnson & Johnson (JNJ) stake by 0.11% in Q2 2026, buying an estimated $233 and bringing the position to 949 shares worth $241K. The position accounts for 0.05% of the portfolio, ranked #76.

Droms Strauss Advisors first reported a position in JNJ in Q4 2019 and has held it in 13 quarters since. The position peaked at $275K in Q4 2019. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Droms Strauss Advisors held 949 shares of Johnson & Johnson worth $241K as of Q2 2026.
  • Droms Strauss Advisors bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.05% of Droms Strauss Advisors's portfolio in Q2 2026, its #76 holding.
  • Droms Strauss Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 13 quarters since.
  • Droms Strauss Advisors's Johnson & Johnson position peaked at $275K in Q4 2019.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Droms Strauss Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.